4AB:ETR
AbbVie Common Stock
€255.00
arrow_upward
+0.24%(+0.60) 1D
Oct 26, 5:35:39 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€254.70
High
€259.00
Low
€254.70
Mkt. cap
504.58B
Avg. vol.
785.00
Volume
279.00
52-wk high
€259.60
52-wk low
€162.85
No. of employees
57K
Open
€254.70
High
€259.00
Low
€254.70
Mkt. cap
504.58B
Avg. vol.
785.00
Volume
279.00
52-wk high
€259.60
52-wk low
€162.85
No. of employees
57K
Related stocks
News stories
From web sources and news partners
Investing News Network
·
5 hours ago
Allergan Aesthetics Celebrates Eight Years of Engaging Girls in STEM Through Continued Partnership with Girls Inc.
24/7 Wall St.
·
6 hours ago
AbbVie Options Price In a Sudden 5% Swing—What Investors Must Know Before Oct. 30
The Motley Fool
·
11 hours ago
Billionaire Ken Griffin Is Buying This Dividend King That Wall Street Still Rates a Buy
Yahoo Finance
·
2 days ago
AbbVie (ABBV) Stock Gets Fair Value Bump After Analyst Target Increases
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com